CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN
The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in children. The results of the studies show that...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2014-12-01
|
| Series: | Voprosy Sovremennoj Pediatrii |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/95 |